To compare the effectiveness of giving triamcinolone acetonide in the lesion through injection and through microneedling in patients of alopecia areata
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Alopecia AreataHealth Condition 2: L639- Alopecia areata, unspecified
- Registration Number
- CTRI/2018/07/014701
- Lead Sponsor
- Department of Dermatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1.Patients with clinical diagnosis of alopecia areata restricted to scalp.
2.Patients with disease of limited area not requiring systemic treatment.
3.Patients above the age of 18 years.
Exclusion Criteria
1.Patients suffering from any significant systemic illness.
2.History of taking intralesional injections or any topical or systemic treatment for alopecia areata in past twelve weeks.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage regrowth and uniformity of regrowth and to compare the efficacy of intralesional triamcinolone acetonide to triamcinolone acetonide through microneedlingTimepoint: 0 weeks <br/ ><br>3 weeks <br/ ><br>6 weeks <br/ ><br>9 weeks <br/ ><br>12 weeks
- Secondary Outcome Measures
Name Time Method Atrophy over the patchTimepoint: 3 weeks, 6 weeks, 9 weeks, 12 weeks;Pigmentation changesTimepoint: 3 weeks, 6 weeks, 9 weeks, 12 weeks;TelangectasiaTimepoint: 3 weeks, 6 weeks, 9 weeks, 12 weeks